DOMESTIC ANTITUMOR COMPOUND 2-[3-(2-CHLOROETHYL)-3-NITROSOUREIDO]-1,3- PROPANEDIOL (CHLONISOL). ACUTE TOXICITY

Мұқаба

Дәйексөз келтіру

Толық мәтін

Аннотация

2-[3-(2-Chloroethyl)-3-nitrosoureido]-1,3-propanediol (Сhlonisol) is a representative of a separate group of derivatives of the class of nitrosoalkylureas – alkylnitrosoureidopropanediols, which are characterized by high antitumor activity on a wide range of experimental tumors. Chlonisol LD50 in male mice for intravenous administration was 35 mg/kg, intraperitoneal – 39 mg/kg, in female mice – 34 mg/kg and 36 mg/kg, respectively. In rats of males with intraperitoneal administration, LD50 was 30 mg/kg, in rats of females – 32 mg/kg. The maximum tolerated dose in mice, rats, guinea pigs and rabbits was 20 mg/kg. The tolerated dose for dogs was a dose of 2 mg/kg. Myelo-depression was a dose-limiting side effect. Lethal and sublethal doses of Chlonisol caused aplasia of the bone marrow and lymphoid organs, damage to the mucous membrane of the gastrointestinal tract, and dystrophic changes in the myocardium, lungs, liver, kidneys, pancreas, and reproductive organs. In the late stages after intraperitoneal administration of sublethal doses of Chlonisol, chylothorax and chyloperitoneum were found in some rats.

Авторлар туралы

A. Stukov

N.N. Petrov Scientifi c Research Center of Oncology, RF Ministry of Health

Хат алмасуға жауапты Автор.
Email: fake@neicon.ru

Stukov Alexander Nikolaevich

197758, Saint Petersburg

Ресей

S. Vershinina

A.M. Granov Russian Research Center for Radiology and Surgical Technologies, RF Ministry of Health

Email: fake@neicon.ru

Vershinina Sofia Fathutdinovna

197758, Saint Petersburg

Ресей

N. Kharitonova

S.M. Kirov Military Medical Academy

Email: natal56@mail.ru

Kharitonova Natalja Nicolaevna

194044, Saint Petersburg

Ресей

L. Filatova

N.N. Petrov Scientifi c Research Center of Oncology, RF Ministry of Health

Email: larisa_filatova@list.ru

Filatova Larisa Valentinovna

197758, Saint Petersburg

Ресей

D. Latipova

N.N. Petrov Scientifi c Research Center of Oncology, RF Ministry of Health

Email: fake@neicon.ru

Latipova Dilorom Hamidovna

197758, Saint Petersburg

Ресей

M. Tyndyk

N.N. Petrov Scientifi c Research Center of Oncology, RF Ministry of Health

Email: fake@neicon.ru

Tyndyk Margarita Leonidovna

197758, Saint Petersburg

Ресей

Yu. Zmitrichenko

N.N. Petrov Scientifi c Research Center of Oncology, RF Ministry of Health

Email: zmitrichenko@gmail.com

Zmitrichenko Yuliya Gennadievna

197758, Saint Petersburg

Ресей

A. Semenov

N.N. Petrov Scientifi c Research Center of Oncology, RF Ministry of Health

Email: genesem7@mail.com

Semenov Alexander Leonidovich

197758, Saint Petersburg

Ресей

V. Bespalov

N.N. Petrov Scientifi c Research Center of Oncology, RF Ministry of Health

Email: bespalov_niio@mail.ru

Bespalov Vladimir Grigorievich

197758, Saint Petersburg

Ресей

T. Semiglazova

N.N. Petrov Scientifi c Research Center of Oncology, RF Ministry of Health

Email: fake@neicon.ru

Semiglazova Tatiana Yuryevna

197758, Saint Petersburg

Ресей

Әдебиет тізімі

  1. Kon’kov S.A., Stukov A.N., Reztsova V.V. etc. Alkylhydroperoxide and alkylatorspodophyllin – new group of anticancer compounds. Oncology Issues. 1998; 44 (1): 97-99 (in Russian).
  2. Ostrovskaya L.A, Filov V.A, Ivin B.A. et al. Chlonizol – the new alkylnitrosourea J drug with antitumor activity. Russian Biotherapeutic ournal. 1998; 3 (1): 37-48 (in Russian).
  3. Stukov A.N., Esikov K.A., Usmanova L.M. et al. Method of synthesis 2-[3-(2-chlorethyl)- 3-nitrosoureido]-1,3-propanediol owned with antitumor activity. Patent RF, № 2678846; 2018 (in Russian).
  4. Stukov A.N., Semiglasova T.Yu., Filatova L.V. et al. Use of the compound 2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3- propanediol for the treatment of HER2- positive tumors in the experiment. Patent R F; № 2695787; 2018 (in Russian)

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Stukov A.N., Vershinina S.F., Kharitonova N.N., Filatova L.V., Latipova D.Н., Tyndyk M.L., Zmitrichenko Y.G., Semenov A.L., Bespalov V.G., Semiglazova T.Y., 2021


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 81728 от 11 декабря 2013.